Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

There hasn’t been an over-the-counter product for genital herpes symptoms in a mainstream drug store – until FemiClear for Genital Herpes Symptoms. While it is important for women to continue their prescription anti-viral medication if their physician has prescribed one, most women still have outbreaks and the symptoms are miserable – itching, pain, and burning. They have been cobbling together their own solutions to manage these symptoms until now.

FemiClear for Genital Herpes Symptoms is made with all-natural and organic ingredients. It’s been proven to kill 99.9% of the Herpes Simplex I and II viruses*. Studies show it reduced the severity of outbreak symptoms – itching, pain, and burning – in >90% of women.**

* Independent accredited laboratory test (non-human/non-animal) measured the antiviral activity of FemiClear using a suspension time-kill procedure against herpes simplex I & II

** As self-reported in a comprehensive IRB approved study of women diagnosed and actively experiencing a genital herpes outbreak. Individual results may vary.

FemiClear should be used as directed. Not a cure for herpes or replacement for prescription antiviral medication.

Claims based on clinical and/or in vitro laboratory (non-human/non-animal) studies, and traditional homeopathic practice (not accepted clinical medical evidence; not FDA evaluated).

OrganiCare offers a range of all-natural and organic first aid, oral care, and feminine care products under two brands, CUROXEN® and FemiClear®.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.